Trading Halt

Aug 27, 2026 at 7:01 PM EDT · Issued by Percheron Therapeutics Limited via ASX

Filed with ASX · Aug 27, 2026 at 7:01 PM EDT

On 6ix: 6ix.com/news/trading-halt-2020

Market Announcement 28 August 2026 28 August 2026 Market Announcement 1/1 ASX Limited ASX Customer Service Centre 131 279 | asx.com.au Percheron Therapeutics Limited (ASX: PER) – Trading Halt Trading in the securities of Percheron Therapeutics Limited (‘PER’) will be...

View Attachment

6ix hasn’t read this filing yet.

Percheron Therapeutics Limited on 6ix

Earlier from Percheron Therapeutics

Vanderbilt Health to conduct clinical trial of HMBD-002Aug 27
Appendix 4E and Annual ReportAug 19
Appendix 4G and Corporate Governance StatementAug 18
Application for quotation of securities - PERAug 14
Notice of date of AGM and other relevant datesAug 11

Later from Percheron Therapeutics

Percheron receives $0.70m R&D Tax Incentive RebateAug 30
Notification of cessation of securities - PERAug 31
Change of Director's Interest NoticeAug 31
Transitional appointment of Executive DirectorAug 31
Initial Director's Interest NoticeAug 31

All Percheron Therapeutics news releases

Follow Percheron Therapeutics into a list and get an email when it puts out news.

Follow Percheron Therapeutics